Global Liquid Biopsy Market Size, Trends and Growth opportunity, By Biomarker Types (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (CTDNA), Extracellular Vesicles (EVS), Circulating RNA and Proteins, By Technology (Multi-gene-parallel Analysis (NGS), Single Gene Analysis (PCR Microarrays)), By Application (Cancer Therapeutic Application, Reproductive Health and Other Therapeutic Application), By Sample (Blood Sample, Urine Sample and other), By End User (Hospitals and Laboratories, Academic and Research Centers and other End Users), Regional Outlook, Competitive Market Share & Forecast, 2022 – 2027.
Global Liquid Biopsy Market 
Global Liquid Biopsy Market was valued at USD 4.2 billion in 2021 and is expected to reach USD 10.5 billion by 2027, at a CAGR 15.60% from 2022-2027.
A Liquid Biopsy, also known as fluid biopsy or fluid phase biopsy, is the sampling and analysis of non-solid biological tissue; primarily blood. A liquid biopsy is a blood test which detects cancerous tumors. As a tumor grows, pieces can break off and circulate in one’s bloodstream. It is a revolutionary technique which is opening previously unexpected perspectives.
Market Drivers
The rapid advances in detection technologies such as digital PCR, multi-panel detection, and advanced cell capture technology are some of the driving factors for the liquid biopsy commercial application of the technology. High efficacy and cost-effectiveness of liquid biopsy over other diagnostic tests are main factors responsible for market growth.
Furthermore, liquid biopsies are used for diagnosing non–small cell lung cancer and screening or as a companion diagnostic for other types of cancers such as colorectal, breast, gastrointestinal, prostate, and ovarian cancer. These factors are boosting the market further.
Market Restraints
Various obstacles that likely pose a challenge to liquid biopsy market growth are; lack of skilled professionals required to operate instruments is a major factor that can restrain the growth. Also, the blood collection in liquid biopsy is a sensitive technique, and single negligence in operation or lack of skill can ruin the process. All these factors can restrain the market growth.
Market Segmentation
The Global Liquid Biopsy Market is segmented into biomarker types, technology, application, samples, and end user. 
Based on biomarker types, the global market is segmented into circulating tumor cells (CTCS), circulating tumor DNA (CTDNA), extracellular vesicles (EVS), and others.
Based on application, the global market has been segmented into cancer, reproductive health, and others.
Regional Analysis
The Global Liquid Biopsy Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the liquid biopsy market share while Asia-Pacific region is the fastest-growing market. The technology of liquid biopsy was developed in the USA and several other European countries, which is reflected in the dominance of these two regions in their respective market share. The European market is projected to grow at the highest CAGR rate.
Key Players
Various key players are discussed into the Global Liquid Biopsy Market Report including: BIOCEPT, INC., Qiagen N.V., Trovagene, Inc, Janssen Global Services, LLC, MDxHealth SA, Natera, Inc, F. Hoffmann-La Roche Ltd, Silicon Biosystems, Pathway Genomics Corporation, Sysmex Corporation, and others.
Market Taxonomy
By Biomarker Type
•    Circulating Tumor Cells 
•    Circulating Tumor DNA
•    Extracellular Vesicles
•    Others (Circulating RNA, Exosome, and Proteins)
By Sample Type
•    Blood Sample
•    Urine Sample
•    Others (Plasma, Saliva, CSF)
By Technology 
•    Multi-gene-parallel Analysis (NGS)
•    Single Gene Analysis (PCR Microarrays)
By Application
•    Cancer Therapeutic Application
•    Reproductive Health
•    Gastrointestinal Cancer
•    Prostate Cancer
•    Breast Cancer
•    Colorectal Cancer
•    Leukemia
•    Others 
By End Users
•    Hospitals
•    Laboratories
•    Academic and Research Centers
•    other
By Region
•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Middle East & Africa

Global Liquid Biopsy Market
1 Introduction    
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Liquid Biopsy Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Liquid Biopsy Market, By Biomarker Type
5.1 Y-o-Y Growth Comparison, By Biomarker Type
5.2 Global Liquid Biopsy Market Share Analysis, By Biomarker Type
5.3 Global Liquid Biopsy Market Size and Forecast, By Biomarker Type
5.3.1 Circulating Tumor Cells
5.3.2 Circulating Tumor DNA
5.3.3 Extracellular Vesicles
5.3.4 Others (Circulating RNA, Exosome, and Proteins)
6 Global Liquid Biopsy Market, By Sample Type
6.1 Y-o-Y Growth Comparison, By Sample Type
6.2 Global Liquid Biopsy Market Share Analysis, By Sample Type
6.3 Global Liquid Biopsy Market Size and Forecast, By Sample Type
6.3.1 Blood Sample
6.3.2 Urine Sample
6.3.3 Others (Plasma, Saliva, CSF)
7 Global Liquid Biopsy Market, By Technology
7.1 Y-o-Y Growth Comparison, By Technology
7.2 Global Liquid Biopsy Market Share Analysis, By Technology
7.3 Global Liquid Biopsy Market Size and Forecast, By Technology
7.3.1 Multi-gene-parallel Analysis (NGS)
7.3.2 Single Gene Analysis (PCR Microarrays)
8 Global Liquid Biopsy Market, By Application
8.1 Y-o-Y Growth Comparison, By Application
8.2 Global Liquid Biopsy Market Share Analysis, By Application
8.3 Global Liquid Biopsy Market Size and Forecast, By Application
8.3.1 Cancer Therapeutic Application
8.3.2 Reproductive Health
8.3.3 Gastrointestinal Cancer
8.3.4 Prostate Cancer
8.3.5 Breast Cancer
8.3.6 Colorectal Cancer
8.3.7 Leukemia
8.3.8 Others
9 Global Liquid Biopsy Market, By End-User
9.1 Y-o-Y Growth Comparison, By End-user
9.2 Global Liquid Biopsy Market Share Analysis, By End-user
9.3 Global Liquid Biopsy Market Size and Forecast, By End-user
9.3.1 Hospitals
9.3.2 Laboratories
9.3.3 Academic and Research Centers
9.3.4 Other
10 Global Liquid Biopsy Market, By Region
10.1 Global Liquid Biopsy Market Share Analysis, By Region
10.2 Global Liquid Biopsy Market Share Analysis, By Region
10.3 Global Liquid Biopsy Market Size and Forecast, By Region
11 North America Liquid Biopsy Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 North America Liquid Biopsy Market Share Analysis, By Propulsion Type
11.3 North America Liquid Biopsy Market Size and Forecast, By Sample Type
11.4 North America Liquid Biopsy Market Size and Forecast, By Technology
11.5 North America Liquid Biopsy Market Size and Forecast, By Application
11.6 North America Liquid Biopsy Market Size and Forecast, By End-User
11.7 North America Liquid Biopsy Market Size and Forecast, By Country
11.7.1 U.S.
11.7.2 Canada
11.7.3 Mexico
12 Europe Liquid Biopsy Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Europe Liquid Biopsy Market Share Analysis, By Biomarker Type
12.3 Europe Liquid Biopsy Market Size and Forecast, By Sample Type
12.4 Europe Liquid Biopsy Market Size and Forecast, By Technology
12.5 Europe Liquid Biopsy Market Size and Forecast, By Application
12.5 Europe Liquid Biopsy Market Size and Forecast, By End-User
12.7 Europe Liquid Biopsy Market Size and Forecast, By Country
12.7.1 Germany
12.7.2 France
12.7.3 UK
12.7.4 Rest of Europe
13 Asia Pacific Liquid Biopsy Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Asia Pacific Liquid Biopsy Market Share Analysis, By Biomarker Type
13.3 Asia Pacific Liquid Biopsy Market Size and Forecast, By Sample Type
13.4 Asia Pacific Liquid Biopsy Market Size and Forecast, By Technology 
13.5 Asia Pacific Liquid Biopsy Market Size and Forecast, By Application
13.6 Asia Pacific Liquid Biopsy Market Size and Forecast, By End-User
13.7 Asia Pacific Liquid Biopsy Market Size and Forecast, By Country
13.7.1 China    
13.7.2 Japan
13.7.3 India
13.7.4 Rest of Asia Pacific
14 Latin America Liquid Biopsy Market Analysis and Forecast (2022-2027)
14.1 Introduction
14.2 Latin America Liquid Biopsy Market Share Analysis, By Biomarker Type
14.3 Latin America Liquid Biopsy Market Size and Forecast, By Sample Type
14.4 Latin America Liquid Biopsy Market Size and Forecast, By Technology 
14.5 Latin America Liquid Biopsy Market Size and Forecast, By Application
14.6 Latin America Liquid Biopsy Market Size and Forecast, By End-User
14.7 Latin America Liquid Biopsy Market Size and Forecast, Country
14.7.1 Brazil
14.7.2 Rest of Latin America
15 Middle East Liquid Biopsy Market Analysis and Forecast (2022-2027)
15.1 Introduction
15.2 Middle East Liquid Biopsy Market Share Analysis, By Biomarker Type
15.3 Middle East Liquid Biopsy Market Size and Forecast, By Sample Type
15.4 Middle East Liquid Biopsy Market Size and Forecast, By Technology
15.5 Middle East Liquid Biopsy Market Size and Forecast, By Application
15.6 Middle East Liquid Biopsy Market Size and Forecast, By End-User
15.7 Middle East Liquid Biopsy Market Size and Forecast, By Country
15.7.1 Saudi Arabia
15.7.2 UAE
15.7.3 Egypt
15.7.4 Kuwait
15.7.5 South Africa
16 Competitive Analysis
16.1 Competition Dashboard
16.2 Market share Analysis of Top Vendors
16.3 Key Development Strategies
17 Company Profiles
17.1 BIOCEPT, INC.
17.1.1 Overview
17.1.2 Offerings
17.1.3 Key Financials
17.1.4 Business Segment & Geographic Overview
17.1.5 Key Market Developments
17.1.6 Key Strategies
17.2 Qiagen N.V.
17.2.1 Overview
17.2.2 Offerings
17.2.3 Key Financials
17.2.4 Business Segment & Geographic Overview
17.2.5 Key Market Developments
17.2.6 Key Strategies
17.3 Trovagene, Inc.
17.3.1 Overview
17.3.2 Offerings
17.3.3 Key Financials
17.3.4 Business Segment & Geographic Overview
17.3.5 Key Market Developments
17.3.6 Key Strategies
17.4 Janssen Global Services, LLC
17.4.1 Overview
17.4.2 Offerings
17.4.3 Key Financials
17.4.4 Business Segment & Geographic Overview
17.4.5 Key Market Developments
16.4.6 Key Strategies
17.5 MDxHealth SA
17.5.1 Overview
17.5.2 Offerings
17.5.3 Key Financials
17.5.4 Business Segment & Geographic Overview
17.5.5 Key Market Developments
17.5.6 Key Strategies
17.6 Natera, Inc
16.6.1 Overview
17.6.2 Offerings
17.6.3 Key Financials
17.6.4 Business Segment & Geographic Overview
17.6.5 Key Market Developments
17.6.6 Key Strategies
17.7 F. Hoffmann-La Roche Ltd.
17.7.1 Overview
17.7.2 Offerings
17.7.3 Key Financials
17.7.4 Business Segment & Geographic Overview
17.7.5 Key Market Developments
17.7.6 Key Strategies    
17.8 Silicon Biosystems
17.8.1 Overview
17.8.2 Offerings
17.8.3 Key Financials
17.8.4 Business Segment & Geographic Overview
17.8.5 Key Market Developments
17.8.6 Key Strategies
17.9 Pathway Genomics Corporation
17.9.1 Overview
17.9.2 Offerings
17.9.3 Key Financials
17.9.4 Business Segment & Geographic Overview
17.9.5 Key Market Developments
17.9.6 Key Strategies
17.10 Sysmex Corporation
17.10.1 Overview
17.10.2 Offerings
17.10.3 Key Financials
17.10.4 Business Segment & Geographic Overview
17.10.5 Key Market Developments
17.10.6 Key Strategies